HEALTHCARE

FathomX

/

Developer of an artificial intelligence-driven technology designed for the detection of breast cancer. The company’s technology offers an artificial intelligence model for mammograms for advanced breast cancer screening to help detect abnormal lesions, estimate one’s risk of developing breast cancer, and automatically generate a radiology report for use by clinicians, enabling medical professionals in the healthcare system to address the increasing cases of breast cancer better and reduce false-positive rates. FathomX is a Digital Health AI spin-off company from the National University of Singapore and National University Health System and is the brainchild of Prof Mikael Hartman (Breast Cancer Surgeon at NUH) and Prof Feng Meng Ling (Assistant Professor at the Saw Swee Hock School of Public Health).

Aevice Health

/

Developer of a chronic respiratory wellness device designed for asthmatic patients. The company’s device records important and relevant historical data regarding respiratory symptoms and medication intake to facilitate the early detection of cardiopulmonary abnormalities remotely and in real-time, enabling patients to receive fast and targeted care from the ease of their homes.

Qritive

/

Developer of an artificial intelligence-powered diagnostic platform designed to assist doctors in analyzing microscopy images and text from patient data. The company’s platform uses artificial intelligence and natural language processing to analyze microscopy images and a patient’s medical history efficiently, enabling medical professionals to improve their efficiency in performing cancer diagnoses. Digitizing the pathology workflow from start to finish, it is a clinically approved, vendor-agnostic ecosystem equipped with a holistic range of features to support pathologists. From case management, AI analysis of whole-slide images, to report generation, it streamlines processes and helps pathologists to focus on what they do best. It opens doors to a world where telepathology and remote diagnosis is possible. With AI modules that are trained to analyze immunohistochemistry, Qritive is able to grade lymphadenopathy, breast, prostate and colon cancer, amongst other diseases, enhancing pathologists’ and physicians’ diagnostic confidence. Ultimately, it improves concordance and optimizes patient outcomes.

Us2.ai 

/

Operator of a machine learning platform intended to provide partners with an end-to-end resolution for cardiovascular research, development, and distribution. The company’s platform automates the manual process of measuring and interpreting echocardiograms and provides artificial intelligence-based decision support tools to save doctors time, improve clinical trials for pharma, and support the detection of routinely missed and hard-to-diagnose conditions for hospitals, enabling physicians to improve the performance of cardiovascular clinical trials.

DocDoc

/

Developer of an artificial intelligence-based healthcare platform designed to empower patients with the information they need to make healthcare decisions. The company’s platform focuses on doctor discovery, telemedicine, and cashless services and enhances the end-to-end healthcare journey, enabling patients to optimize healthcare outcomes and costs.

Vivance

/

Developer of ultraportable dialysis devices designed for chronic kidney disease management. The company’s system uses sorbent technology which regenerates and reconstitutes used dialysis fluid into fresh fluid and provides the necessary clearances of the uremic toxins, enabling patients to reduce treatment burden through a more convenient dialysis experience.

Doctor Anywhere

/

Developer of a healthcare platform designed to combine a full range of health and wellness services into a single, integrated platform. The company’s platform specializes in offering consultations conducted by licensed and authorized doctors who provide appropriate diagnoses, medication, and e-prescriptions, enabling patients to consult with a licensed medical professional anywhere and at any time.

Biofourmis

/

Hospital at Home: A scalable solution that uses continuous and episodic monitoring, AI-enabled analytics, and coordinated in-home services to deliver care to clinically-appropriate acute patients at home. Timely Discharge: A comprehensive care delivery solution that combines our acute and post-acute care capabilities, for patients to complete the last 1-2 days of their hospital stay at home, and receive remote patient management for post-acute care. SNF at Home: Care delivery solution for patients requiring skilled nursing or therapy post-discharge that includes clinical and ancillary services, virtual visits, and remote monitoring for patients to receive high-quality care in their home. Remote patient management: A virtual care solution, enabled by personalized care plans, remote patient management, and patient engagement tools to help prevent decompensation post-discharge and reduce re-hospitalizations.

Medi Lifestyle Ltd

/

Medi Lifestyle Limited, an investment holding company, provides healthcare and wellness services in Malaysia and Singapore. The company operates through Healthcare and Outsourced Services segments. It offers postnatal recovery services under the NADORA brand; and alternative medicines and physical therapy services, such as chiropractic and physiotherapy, and traditional Chinese medicines under the Back to Life brand name. The company also provides generic profiling services to screen for various potential health risks and health traits related to diseases under the Qodify brand name. In addition, it distributes brain trauma test kits and LS-4000 dry fluorescence immunoassay analyzers under the LansionBio brand name. Further, the company offers confinement, recruitment, digital marketing and e-commerce, consultancy, business process outsourcing, human resource and payroll, and permanent placement services; and distributes pharmaceutical and medical products. Additionally, it operates a postpartum care center, and chiropractic and physiotherapy centers.

AsiaMedic Ltd

/

AsiaMedic Limited, an investment holding company, provides healthcare services in Singapore. The company offers diagnostic imaging, radiology, health screening, and medical wellness services. It also provides medical aesthetic products and related services. In addition, the company provides medical imaging services, such as computerized and positron emission tomography; bone mineral densitometry, and magnetic resonance imaging, as well as ultrasound scanning and X-ray. Further, it operates aesthetic clinics. Additionally, the company sells pharmaceutical and aesthetic related products. The company was incorporated in 1974 and is based in Singapore.

Scroll to Top